Snapshot
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.
The global Biosimilars market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Injection
Tablets
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Sandoz International
Hospira
Teva Pharmaceutical
Dr. Reddy's Laboratories
Biocon
Mylan
Amgen
Celltrion
Roche Diagnostics
Merck KGaA
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Biosimilars Industry
Figure Biosimilars Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Biosimilars
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Biosimilars
1.2.2 Downstream
Table Application Segment of Biosimilars
Table Global Biosimilars Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Biosimilars Market by Type
3.1 By Type
3.1.1 Injection
Table Major Company List of Injection
3.1.2 Tablets
Table Major Company List of Tablets
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Biosimilars Market 2016-2020, by Type, in USD Million
Figure Global Biosimilars Market Growth 2016-2020, by Type, in USD Million
Table Global Biosimilars Market 2016-2020, by Type, in Volume
Figure Global Biosimilars Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Biosimilars Market Forecast 2021-2026, by Type, in USD Million
Table Global Biosimilars Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Sandoz International (Company Profile, Sales Data etc.)
4.1.1 Sandoz International Profile
Table Sandoz International Overview List
4.1.2 Sandoz International Products & Services
4.1.3 Sandoz International Business Operation Conditions
Table Business Operation of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Hospira (Company Profile, Sales Data etc.)
4.2.1 Hospira Profile
Table Hospira Overview List
4.2.2 Hospira Products & Services
4.2.3 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Teva Pharmaceutical (Company Profile, Sales Data etc.)
4.3.1 Teva Pharmaceutical Profile
Table Teva Pharmaceutical Overview List
4.3.2 Teva Pharmaceutical Products & Services
4.3.3 Teva Pharmaceutical Business Operation Conditions
Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Dr. Reddy's Laboratories (Company Profile, Sales Data etc.)
4.4.1 Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Overview List
4.4.2 Dr. Reddy's Laboratories Products & Services
4.4.3 Dr. Reddy's Laboratories Business Operation Conditions
Table Business Operation of Dr. Reddy's Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Biocon (Company Profile, Sales Data etc.)
4.5.1 Biocon Profile
Table Biocon Overview List
4.5.2 Biocon Products & Services
4.5.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Mylan (Company Profile, Sales Data etc.)
4.6.1 Mylan Profile
Table Mylan Overview List
4.6.2 Mylan Products & Services
4.6.3 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Amgen (Company Profile, Sales Data etc.)
4.7.1 Amgen Profile
Table Amgen Overview List
4.7.2 Amgen Products & Services
4.7.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Celltrion (Company Profile, Sales Data etc.)
4.8.1 Celltrion Profile
Table Celltrion Overview List
4.8.2 Celltrion Products & Services
4.8.3 Celltrion Business Operation Conditions
Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Roche Diagnostics (Company Profile, Sales Data etc.)
4.9.1 Roche Diagnostics Profile
Table Roche Diagnostics Overview List
4.9.2 Roche Diagnostics Products & Services
4.9.3 Roche Diagnostics Business Operation Conditions
Table Business Operation of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Merck KGaA (Company Profile, Sales Data etc.)
4.10.1 Merck KGaA Profile
Table Merck KGaA Overview List
4.10.2 Merck KGaA Products & Services
4.10.3 Merck KGaA Business Operation Conditions
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
Table Global Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
Table Global Biosimilars Sales Volume 2016-2020, by Company, in Volume
Table Global Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Biosimilars Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Biosimilars Market Concentration, in 2020
Figure Europe Biosimilars Market Market Concentration, in 2020
Figure Asia-Pacific Biosimilars MMarket Concentration, in 2020
Figure South America Biosimilars Market Concentration, in 2020
Figure Middle East & Africa Biosimilars Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Ankylosing Spondylitis
Figure Biosimilars Demand in Ankylosing Spondylitis, 2016-2020, in USD Million
Figure Biosimilars Demand in Ankylosing Spondylitis, 2016-2020, in Volume
6.1.2 Demand in Tumor
Figure Biosimilars Demand in Tumor, 2016-2020, in USD Million
Figure Biosimilars Demand in Tumor, 2016-2020, in Volume
6.1.3 Demand in Rheumatoid Arthrtis
Figure Biosimilars Demand in Rheumatoid Arthrtis, 2016-2020, in USD Million
Figure Biosimilars Demand in Rheumatoid Arthrtis, 2016-2020, in Volume
6.1.4 Demand in Cardiovascular
Figure Biosimilars Demand in Cardiovascular, 2016-2020, in USD Million
Figure Biosimilars Demand in Cardiovascular, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
Figure Biosimilars Market Growth 2021-2026, by Application, in USD Million
Figure Biosimilars Market Share in 2026, by Application, in USD Million
Table Biosimilars Demand Forecast 2021-2026, by Application, in Volume
Table Biosimilars Market Growth 2021-2026, by Application, in Volume
Table Biosimilars Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Biosimilars Production 2016-2020, by Region, in USD Million
Table Biosimilars Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Biosimilars Market 2016-2020, by Region, in USD Million
Table Global Biosimilars Market Share 2016-2020, by Region, in USD Million
Table Global Biosimilars Market 2016-2020, by Region, in Volume
Table Global Biosimilars Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure North America Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Biosimilars Market Size 2016-2020, by Country, in USD Million
Table North America Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Europe Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Europe Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure South America Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Biosimilars Market Size 2016-2020, by Country, in USD Million
Table South America Biosimilars Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Biosimilars Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Biosimilars Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Biosimilars Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Biosimilars Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Biosimilars Market Forecast 2021-2026, by Region, in USD Million
Table Biosimilars Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Biosimilars
2. Table Application Segment of Biosimilars
3. Table Global Biosimilars Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Tablets
5. Table Major Company List of Others
6. Table Global Biosimilars Market 2016-2020, by Type, in USD Million
7. Table Global Biosimilars Market 2016-2020, by Type, in Volume
8. Table Global Biosimilars Market Forecast 2021-2026, by Type, in USD Million
9. Table Global Biosimilars Market Forecast 2021-2026, by Type, in Volume
10. Table Sandoz International Overview List
11. Table Business Operation of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
12. Table Hospira Overview List
13. Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
14. Table Teva Pharmaceutical Overview List
15. Table Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table Dr. Reddy's Laboratories Overview List
17. Table Business Operation of Dr. Reddy's Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Biocon Overview List
19. Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Mylan Overview List
21. Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Amgen Overview List
23. Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Celltrion Overview List
25. Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Roche Diagnostics Overview List
27. Table Business Operation of Roche Diagnostics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Merck KGaA Overview List
29. Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table Global Biosimilars Sales Revenue 2016-2020, by Company, in USD Million
31. Table Global Biosimilars Sales Revenue Share 2016-2020, by Company, in USD Million
32. Table Global Biosimilars Sales Volume 2016-2020, by Company, in Volume
33. Table Global Biosimilars Sales Volume Share 2016-2020, by Company, in Volume
34. Table Regional Demand Comparison List
35. Table Major Application in Different Regions
36. Table Biosimilars Demand Forecast 2021-2026, by Application, in USD Million
37. Table Biosimilars Demand Forecast 2021-2026, by Application, in Volume
38. Table Biosimilars Market Growth 2021-2026, by Application, in Volume
39. Table Biosimilars Market Share in 2026, by Application, in Volume
40. Table Biosimilars Production 2016-2020, by Region, in USD Million
41. Table Biosimilars Production 2016-2020, by Region, in Volume
42. Table Global Biosimilars Market 2016-2020, by Region, in USD Million
43. Table Global Biosimilars Market Share 2016-2020, by Region, in USD Million
44. Table Global Biosimilars Market 2016-2020, by Region, in Volume
45. Table Global Biosimilars Market Share 2016-2020, by Region, in Volume
46. Table North America Biosimilars Market Size 2016-2020, by Country, in USD Million
47. Table North America Biosimilars Market Size 2016-2020, by Country, in Volume
48. Table Europe Biosimilars Market Size 2016-2020, by Country, in USD Million
49. Table Europe Biosimilars Market Size 2016-2020, by Country, in Volume
50. Table Asia-Pacific Biosimilars Market Size 2016-2020, by Country, in USD Million
51. Table Asia-Pacific Biosimilars Market Size 2016-2020, by Country, in Volume
52. Table South America Biosimilars Market Size 2016-2020, by Country, in USD Million
53. Table South America Biosimilars Market Size 2016-2020, by Country, in Volume
54. Table Middle East & Africa Biosimilars Market Size 2016-2020, by Country, in USD Million
55. Table Middle East & Africa Biosimilars Market Size 2016-2020, by Country, in Volume
56. Table Biosimilars Market Forecast 2021-2026, by Region, in USD Million
57. Table Biosimilars Market Forecast 2021-2026, by Region, in Volume
58. Table Price Factors List
List of Figure
1. Figure Biosimilars Industry Chain Structure
2. Figure Global Biosimilars Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Biosimilars Market Growth 2016-2020, by Type, in Volume
4. Figure Global Biosimilars Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Biosimilars Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Biosimilars Market Concentration, in 2020
7. Figure Europe Biosimilars Market Market Concentration, in 2020
8. Figure Asia-Pacific Biosimilars MMarket Concentration, in 2020
9. Figure South America Biosimilars Market Concentration, in 2020
10. Figure Middle East & Africa Biosimilars Market Concentration, in 2020
11. Figure Biosimilars Demand in Ankylosing Spondylitis, 2016-2020, in USD Million
12. Figure Biosimilars Demand in Ankylosing Spondylitis, 2016-2020, in Volume
13. Figure Biosimilars Demand in Tumor, 2016-2020, in USD Million
14. Figure Biosimilars Demand in Tumor, 2016-2020, in Volume
15. Figure Biosimilars Demand in Rheumatoid Arthrtis, 2016-2020, in USD Million
16. Figure Biosimilars Demand in Rheumatoid Arthrtis, 2016-2020, in Volume
17. Figure Biosimilars Demand in Cardiovascular, 2016-2020, in USD Million
18. Figure Biosimilars Demand in Cardiovascular, 2016-2020, in Volume
19. Figure Biosimilars Market Growth 2021-2026, by Application, in USD Million
20. Figure Biosimilars Market Share in 2026, by Application, in USD Million
21. Figure North America Biosimilars Market Size and Growth 2016-2020, in USD Million
22. Figure North America Biosimilars Market Size and Growth 2016-2020, in Volume
23. Figure Europe Biosimilars Market Size and Growth 2016-2020, in USD Million
24. Figure Europe Biosimilars Market Size and Growth 2016-2020, in Volume
25. Figure Asia-Pacific Biosimilars Market Size and Growth 2016-2020, in USD Million
26. Figure Asia-Pacific Biosimilars Market Size and Growth 2016-2020, in Volume
27. Figure South America Biosimilars Market Size and Growth 2016-2020, in USD Million
28. Figure South America Biosimilars Market Size and Growth 2016-2020, in Volume
29. Figure Middle East & Africa Biosimilars Market Size and Growth 2016-2020, in USD Million
30. Figure Middle East & Africa Biosimilars Market Size and Growth 2016-2020, in Volume
31. Figure Marketing Channels Overview
Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology...
Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...
North America bioprocess technology market is projected to grow by 13.3% annually in the forecast period and reach $29.68 billion by 2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology s...
Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technologic...
Asia Pacific biopharmaceuticals market will grow by 10.3% annually with a total addressable market cap of $1,776.7 billion over 2024-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discove...
Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...
North America biopharmaceuticals market is projected to grow by 8.4% annually in the forecast period and reach $407.2 billion by 2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, ...
Global biopharmaceuticals market will reach $1,001.1 billion by 2033, growing by 8.8% annually over 2023-2033. The growth is driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing cl...
Overview of the Global Biosimilars & Follow-on-Biologics Market:
The report discusses everything a marketer requires before investing in the global Biosimilars & Follow-on-Biologics Market during the forecast period...
The global Biosimilars market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field ev...